SUZANNE MEEKS: Open Payments
NPI 1679746044 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 20 payments from 10 companies in 2025. Trend: 2023 $925 · 2024 $721 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $100 |
| Novo Nordisk Inc | 4 | $87 |
| ABBVIE INC. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: XIFAXAN, Rybelsus, QULIPTA, AIRSUPRA, TRELEGY ELLIPTA, Veozah, XYOSTED, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
